ABM 临床实践协议 #21：母乳喂养和药物依赖妇女指南。
ABM clinical protocol #21: Guidelines for breastfeeding and the drug-dependent woman.
出版信息
Breastfeed Med. 2009 Dec;4(4):225-8. doi: 10.1089/bfm.2009.9987.
Abstract
A central goal of The Academy of Breastfeeding Medicine is the development of clinical protocols for managing common medical problems that may impact breastfeeding success. These protocols serve only as guidelines for the care of breastfeeding mothers and infants and do not delineate an exclusive course of treatment or serve as standards of medical care. Variations in treatment may be appropriate according to the needs of an individual patient.
摘要
母乳喂养医学会的一个核心目标是制定管理可能影响母乳喂养成功的常见医疗问题的临床方案。这些方案仅作为母乳喂养母亲和婴儿护理的指南，并不规定专门的治疗方案，也不作为医疗保健标准。根据患者的具体需求，治疗方法可能会有所不同。
相似文献
1
ABM clinical protocol #21: Guidelines for breastfeeding and the drug-dependent woman.ABM 临床实践协议 #21：母乳喂养和药物依赖妇女指南。
Breastfeed Med. 2009 Dec;4(4):225-8. doi: 10.1089/bfm.2009.9987.
2
ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015.美国母乳喂养医学学会临床方案#21：母乳喂养与物质使用或物质使用障碍指南，2015年修订版
Breastfeed Med. 2015 Apr;10(3):135-41. doi: 10.1089/bfm.2015.9992.
3
ABM Clinical Protocol #32: Management of Hyperlactation.ABM临床方案#32：乳汁过多的管理。
Breastfeed Med. 2020 Mar;15(3):129-134. doi: 10.1089/bfm.2019.29141.hmj. Epub 2020 Feb 6.
4
ABM Clinical Protocol #9: Use of Galactogogues in Initiating or Augmenting Maternal Milk Production, Second Revision 2018.ABM临床方案#9：催乳剂在启动或增加母乳分泌中的应用，2018年第二版修订本
Breastfeed Med. 2018 Jun;13(5):307-314. doi: 10.1089/bfm.2018.29092.wjb.
5
ABM Clinical Protocol #3: Supplementary Feedings in the Healthy Term Breastfed Neonate, Revised 2017.美国儿科学会临床协议#3：健康足月儿母乳喂养的补充喂养，2017年修订版
Breastfeed Med. 2017 May;12:188-198. doi: 10.1089/bfm.2017.29038.ajk. Epub 2017 Mar 15.
6
ABM Clinical Protocol #9: Use of galactogogues in initiating or augmenting the rate of maternal milk secretion (First Revision January 2011).ABM 临床实践规程 #9：利用催奶剂启动或增加母乳分泌量（第一次修订版，2011 年 1 月）。
Breastfeed Med. 2011 Feb;6(1):41-9. doi: 10.1089/bfm.2011.9998.
7
ABM clinical protocol #20: Engorgement.ABM临床方案#20：乳胀。
Breastfeed Med. 2009 Jun;4(2):111-3. doi: 10.1089/bfm.2009.9997.
8
ABM Clinical Protocol #27: Breastfeeding an Infant or Young Child with Insulin-Dependent Diabetes.ABM临床方案#27：为患有胰岛素依赖型糖尿病的婴幼儿哺乳。
Breastfeed Med. 2017 Mar;12:72-76. doi: 10.1089/bfm.2017.29035.djm. Epub 2017 Jan 30.
9
ABM Clinical Protocol #10: Breastfeeding the Late Preterm (34-36 6/7 Weeks of Gestation) and Early Term Infants (37-38 6/7 Weeks of Gestation), Second Revision 2016.ABM临床方案#10：晚期早产儿（妊娠34 - 36 6/7周）和早期足月儿（妊娠37 - 38 6/7周）的母乳喂养，2016年第二次修订版
Breastfeed Med. 2016 Dec;11:494-500. doi: 10.1089/bfm.2016.29031.egb. Epub 2016 Nov 10.
10
ABM Clinical Protocol #23: Nonpharmacological Management of Procedure-Related Pain in the Breastfeeding Infant, Revised 2016.美国母乳喂养医学学会临床协议 #23：母乳喂养婴儿与操作相关疼痛的非药物管理，2016年修订版
Breastfeed Med. 2016 Nov;11:425-429. doi: 10.1089/bfm.2016.29025.srs. Epub 2016 Sep 13.
引用本文的文献
1
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids.未来患有阿片类药物所致新生儿戒断综合征（NAS）的新生儿可通过遗传成瘾风险严重程度（GARS）测试进行评估，并有可能采用精准氨基酸脑啡肽酶抑制疗法（KB220）作为一线治疗方式，而非强效阿片类药物进行治疗。
J Pers Med. 2022 Dec 6;12(12):2015. doi: 10.3390/jpm12122015.
2
Non-pharmacological care for opioid withdrawal in newborns.新生儿阿片类戒断的非药物护理。
Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD013217. doi: 10.1002/14651858.CD013217.pub2.
3
Lactose-free infant formula does not change outcomes of neonatal abstinence syndrome (NAS): a randomized clinical trial.无乳糖婴儿配方奶粉不会改变新生儿戒断综合征（NAS）的结局：一项随机临床试验。
J Perinatol. 2021 Mar;41(3):598-605. doi: 10.1038/s41372-020-00797-7. Epub 2020 Aug 31.
4
Opioid use disorder in pregnancy.孕期阿片类药物使用障碍
Ment Health Clin. 2019 Nov 27;9(6):359-372. doi: 10.9740/mhc.2019.11.359. eCollection 2019 Nov.
5
Neonatal Abstinence Syndrome.新生儿戒断综合征
Pediatr Clin North Am. 2019 Apr;66(2):353-367. doi: 10.1016/j.pcl.2018.12.006.
6
Infant Dietary Exposures to Environmental Chemicals and Infant/Child Health: A Critical Assessment of the Literature.婴儿膳食环境化学物质暴露与婴儿/儿童健康：文献批判性评估。
Environ Health Perspect. 2018 Sep;126(9):96002. doi: 10.1289/EHP1954.
7
Environmental Chemicals in Breast Milk and Formula: Exposure and Risk Assessment Implications.母乳和配方奶中的环境化学物质：暴露和风险评估的影响。
Environ Health Perspect. 2018 Sep;126(9):96001. doi: 10.1289/EHP1953.
8
Decreasing Total Medication Exposure and Length of Stay While Completing Withdrawal for Neonatal Abstinence Syndrome during the Neonatal Hospital Stay.在新生儿住院期间完成新生儿戒断综合征戒断时减少总药物暴露量和住院时间。
Front Pediatr. 2017 Oct 10;5:216. doi: 10.3389/fped.2017.00216. eCollection 2017.
9
Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation.孕期阿片类药物使用、新生儿戒断综合征及儿童期结局：尤妮斯·肯尼迪·施莱佛国家儿童健康与人类发展研究所、美国妇产科医师学会、美国儿科学会、母胎医学协会、疾病控制与预防中心以及美国疾病防控中心和“美邦”基金会联合研讨会执行摘要
Obstet Gynecol. 2017 Jul;130(1):10-28. doi: 10.1097/AOG.0000000000002054.
10
In Utero Oxcarbazepine Exposure and Neonatal Abstinence Syndrome: Case Report and Brief Review of the Literature.宫内暴露于奥卡西平与新生儿戒断综合征：病例报告及文献简要综述
Pharmacotherapy. 2017 Jul;37(7):e71-e75. doi: 10.1002/phar.1955. Epub 2017 Jul 2.
本文引用的文献
1
Methadone maintenance and long-term lactation.美沙酮维持治疗与长期哺乳。
Breastfeed Med. 2008 Mar;3(1):34-7. doi: 10.1089/bfm.2007.0032.
2
Methadone maintenance and breastfeeding in the neonatal period.美沙酮维持治疗与新生儿期母乳喂养
Pediatrics. 2008 Jan;121(1):106-14. doi: 10.1542/peds.2007-1182.
3
Concentrations of methadone in breast milk and plasma in the immediate perinatal period.围产期即刻母乳和血浆中的美沙酮浓度。
J Hum Lact. 2007 May;23(2):184-90. doi: 10.1177/0890334407300336.
4
Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers.母乳对药物依赖母亲所生婴儿新生儿戒断综合征严重程度及结局的影响。
Pediatrics. 2006 Jun;117(6):e1163-9. doi: 10.1542/peds.2005-1561.
5
Buprenorphine and norbuprenorphine concentrations in human breast milk samples determined by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法测定人母乳样本中丁丙诺啡和去甲丁丙诺啡的浓度。
Ther Drug Monit. 2005 Aug;27(4):526-30. doi: 10.1097/01.ftd.0000164612.83932.be.
6
Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources.瑞士围产期中心的孕期美沙酮维持治疗项目（II）：新生儿结局与社会资源
Acta Obstet Gynecol Scand. 2005 Feb;84(2):145-50. doi: 10.1111/j.0001-6349.2005.00510.x.
7
Methadone maintenance and lactation: a review of the literature and current management guidelines.
J Hum Lact. 2004 Feb;20(1):62-71. doi: 10.1177/0890334403261027.
8
Treatment of neonatal abstinence syndrome with breast milk containing methadone.用含美沙酮的母乳治疗新生儿戒断综合征。
J Perinat Neonatal Nurs. 2002 Mar;15(4):76-85. doi: 10.1097/00005237-200203000-00008.
9
Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing.多次中高剂量口服给药期间美沙酮R型和S型异构体在人乳中的分布情况。
Br J Clin Pharmacol. 2001 Dec;52(6):681-5. doi: 10.1046/j.0306-5251.2001.01506.x.
10
Detection of cocaine and its metabolites in breast milk.
J Forensic Sci. 2001 Sep;46(5):1221-3.
Zotero 插件